Cathay Biotech

Cathay Biotech Liabilities

The The Liabilities of Cathay Biotech (688065.SS) as of Nov 22, 2026 is -21.22 B CNY. In the previous year, The Liabilities was 3.92 B CNY — a change of -641.19% (lower).

Liabilities

-21.22 BCNY

YoY

-641.19%

Last updated:

In 2025, Cathay Biotech's total liabilities amounted to -21.22 B CNY, a -641.19% difference from the 3.92 B CNY total liabilities in the previous year.

The Cathay Biotech Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
1.68 B CNY
Jan 1, 2019
1.34 B CNY
Jan 1, 2020
650.74 M CNY
Jan 1, 2021
1.51 B CNY
Jan 1, 2022
2.79 B CNY
Jan 1, 2023
4.06 B CNY
Jan 1, 2024
3.92 B CNY
Jan 1, 2025
-21.22 B CNY
The Cathay Biotech Liabilities history
YEARLiabilitiesYoY
-21.22 BCNY-641.19%
3.92 BCNY-3.44%
4.06 BCNY+45.58%
2.79 BCNY+84.61%
1.51 BCNY+132.16%
650.74 MCNY-51.43%
1.34 BCNY-20.38%
1.68 BCNY+79.68%
936.58 MCNY+113.24%
439.21 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cathay Biotech Stock analysis

What does Cathay Biotech do? Cathay Biotech Inc. generates revenue through the research and development, production, and sales of new bio-based materials. The firm's primary offerings include biological long-chain dibasic acids and bio-based polyamide series, such as lauric acid and brazilian acid. These products serve various industrial applications, including long-chain polyamides, fragrances, hot melt adhesives, lubricants, and powder coatings. The company distributes its products to both domestic and overseas markets. This global reach allows Cathay Biotech Inc. to capture value from a broad customer base across different regions. The business model relies on the continuous development and commercialization of these specialized bio-based chemical solutions. Cathay Biotech is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Cathay Biotech's Liabilities

Cathay Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cathay Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Cathay Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Cathay Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Cathay Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Cathay Biotech stock

The Liabilities of Cathay Biotech is -21.22 B CNY in 2025.

The Liabilities of Cathay Biotech changed from 3.92 B CNY to -21.22 B CNY, representing a -641.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Cathay Biotech since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Cathay Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cathay Biotech

All Key Metrics — Cathay Biotech